News
Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.
OpenAI’s contract clause could cut off Microsoft’s access to new AI models if AGI is declared, forcing high-stakes renegotiation of their partnership.
Microsoft has unveiled BioEmu, an advanced AI tool that can simulate protein behavior in mere hours—work that usually takes ...
Microsoft’s new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya ...
Microsoft is laying off thousands of employees, even as its profits and stock price hit historic highs. For many worried ...
Satya Nadella stresses AI must deliver real-world value amid rising job cuts, energy usage, and Microsoft's major AI-led ...
Nvidia and Microsoft are making history as they reach a $4 trillion market cap, highlighting AI's transformative power and ...
The Power of Buy-and-Hold Investing Buy-and-hold investing is a time-tested strategy that rewards patience and a long-term ...
Wedbush said Microsoft (MSFT) is next in line to the $4T market cap club, after Nvidia (NVDA) breached the mark on Wednesday, ...
In head-to-head tests, Microsoft’s virtual medical council diagnosed correctly four times more often than human doctors, and ...
Microsoft is laying off thousands of workers, its second mass layoff in months and its largest in more than two years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results